Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation

W B Coleman1, G J Tsongalis

  • 1Department of Pathology, University of North Carolina School of Medicine, Chapel Hill 27599, USA.

Clinical Chemistry
|May 1, 1995
PubMed

Insights

Genomic instability, characterized by mutations and chromosomal aberrations, can drive cancer development. Alterations in DNA repair, cell cycle control, and proto-oncogenes in normal cells may lead to neoplasia.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Neoplastic cells exhibit extensive genomic mutations and chromosomal aberrations, crucial for carcinogenesis.
  • Cellular homeostasis relies on DNA replication, repair, and cell cycle proteins; alterations in these pathways can cause genomic instability.
  • Loss of protective mechanisms against mutation can lead to accumulated genetic damage, potentially causing neoplastic transformation.

Purpose of the Study:

  • To explore molecular mechanisms underlying DNA mutation and genomic instability in normal cells.
  • To elucidate how these mechanisms contribute to the development of neoplasia (cancer).

Main Methods:

  • The study discusses theoretical molecular mechanisms.
  • It reviews known cellular processes involved in DNA replication and repair.

Main Results:

  • Genomic instability in somatic cells can arise from alterations in DNA repair enzymes.
  • Dysregulation of cell-cycle control mechanisms contributes to genomic instability.
  • Direct molecular alterations of proto-oncogenes can lead to neoplastic transformation.
  • Normal cellular processes like DNA replication timing and repair efficiency can influence gene mutation rates.

Conclusions:

  • Interactions between fundamental cellular processes are vital for maintaining genomic stability.
  • Disruptions in these processes can initiate progressive genomic instability and phenotypic evolution, characteristic of cancer development.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).